Regulatory Nexus
Regulatory
Nexus
Built for regulated submission operations
AI-assisted control for authority-ready dossiers
What Defines FDA Path
FDA Path is a regulatory technology company for life sciences organizations that manage complex electronic submission operations. We build governed, AI-assisted workflows for regulated dossiers, authority-specific requirements, validation preparation, lifecycle continuity, and submission readiness across major health-authority pathways and regional regulatory environments.
The FDA Path Platform
01
Submission Architecture
Build and manage dossier structures with clearer ownership of documents, modules, sequences, regional requirements, and lifecycle relationships. FDA Path gives teams a controlled environment for assembling regulated electronic submissions with fewer disconnected handoffs.
02
AI-Powered Compliance Intelligence
Analyze files, PDFs, technical conditions, naming patterns, structural gaps, and submission-context risk signals before they become blocking issues. The AI does not replace regulatory judgment; it helps teams see what manual review can miss.
03
Validation & Lifecycle Readiness
Prepare for validation, review, publishing, and future sequence maintenance with traceable relationships between current content, prior versions, replacement actions, and submission history.
How FDA Path Enters Your Regulatory Operation
FDA Path is introduced as part of a broader operating model conversation, not as a plug-in purchased in isolation.
What Leadership Teams Should Expect
A serious regulatory platform should strengthen submission discipline across the organization, not simply accelerate a final output step.
Operating Model
Control
Operating Model Control
Build submission work on governed workflows, defined roles, documented handoffs, and repeatable review points across regulatory operations.
Compliance Visibility
Visibility
See hidden document and technical risks earlier, before they emerge under deadline pressure.
Future Standards
Readiness
Future Standards / Readiness / Build a platform foundation for today’s eCTD execution and tomorrow’s regional, metadata-rich, structured submission expectations.
Principles
What We Believe
S
“Submission integrity is built through disciplined systems, not emergency recovery.”
FDA Path Operating Principle
Regulatory Operations
A
“Artificial intelligence matters when it reveals what teams would otherwise miss and keeps human judgment at the center.”
Our AI Philosophy
Responsible Intelligence
F
“Future standards should be designed into the architecture, not patched in after the market has already moved.”
FDA Path Principle
Standards Readiness
Who We Build For
Emerging Biotech & First Submission Teams
For teams preparing early health-authority submissions with limited internal publishing infrastructure and a need to establish disciplined, software-supported readiness.
$5999
/year
Plan Includes:
- Executive discovery session
- Workflow and risk review
- Use-case alignment
- Platform walkthrough
Regulatory Operations & Publishing Teams
For organizations that need repeatable submission workflows across products, amendments, supplements, variations, or recurring lifecycle activity.
$13999
/year
Plan Includes:
- Configuration guidance
- Core workflow setup
- Team enablement
- Early adoption support
Enterprise & Multi-Region Programs
For life sciences organizations managing multi-product, multi-team, or multi-region submission operations across evolving health-authority expectations.
$15999
/year
Plan Includes:
- Multi-team rollout planning
- Governance alignment
- Advanced workflow design
- Strategic partnership support
Why FDA Path Exists
FDA Path exists because regulatory teams deserve software that respects the weight of health-authority submission work. Regulated dossiers are not ordinary document projects; they carry technical rules, lifecycle history, file-format risk, regional requirements, timing pressure, and organizational accountability. We build technology for the people who must turn that complexity into a submission process leadership can trust.
Our Mission
To give life sciences teams a governed, AI-assisted platform for regulated electronic submissions – one that improves compliance visibility, strengthens submission discipline, and prepares organizations for the next era of global eCTD and health-authority standards.
Our Culture
We build with regulatory seriousness, engineering precision, responsible AI, evidence-based product decisions, and respect for the operators who carry submission accountability every day.
Bring stronger intelligence to regulated submission operations.
Whether you are preparing an early health-authority dossier, improving an existing publishing process, expanding across regional submission pathways, or building readiness for eCTD 4.0 and evolving global standards, FDA Path can help you define a more controlled path forward.
Request a Platform Briefing
Explore the Platform
Receive Regulatory Submission Intelligence Updates.
Stay informed on global eCTD standards, authority submission operations, AI-assisted compliance intelligence, and the future of regulated dossier readiness.